Current filters:


Popular Filters

7894 to 7918 of 8454 results

Amgen in up to 695 million-euro BiTE antibody deal with Micromet


US drug discovery firm Micromet (Nasdaq: MITI) stands to earns as much as 695 million euros ($991 million)…


Gilead to boost HIV/hep B drug access via link with Medicine Patent Pool


The Medicines Patent Pool (which was set up in 2010 by UNITAID)revealed this morning that it has entered…

Anti-viralscobicistatelvitegravirEmtrivaGilead SciencesMarkets & MarketingPharmaceuticalViread

Substantial income expected for drug companies operating in Germany, says BMI


Despite the threat of austerity measures, the German government's focus on cost-containment within the…

EuropeMarkets & MarketingPharmaceuticalPoliticsPricing

Valeant to buy Sanofi’s skin care unit Dermik for $425 million


Canada’s Valeant Pharmaceuticals International (TSX: VRX) has entered into an agreement to acquire…

DermatologicalsDermikMergers & AcquisitionsNorth AmericaPharmaceuticalSanofiValeant Pharmaceuticals

Hikma takes stake in China’s Hubei Haosun to enhance API sourcing


Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has acquired…

GenericsHikma PharmaceuticalsHubei HaosunMergers & AcquisitionsOncology

Sanofi Pasteur to start production of vaccines in Ukraine


Sanofi Pasteur, the vaccines division of French drug major Sanofi (Euronext: SAN), has joined with the…

EuropeFarmeksMarkets & MarketingPharmaceuticalSanofiSanofi PasteurVaccines

AMD and diabetic retinopathy drugs market to reach $5.08 billion by 2014, says Visiongain


The market for age-related macular degeneration (AMD) and diabetic retinopathy (DR) drugs will reach…

BayerEyleaLucentisMarkets & MarketingOphthalmicsPharmaceuticalRegeneronRoche

Lilly CEO warns that Germany’s health reforms are harming innovation


Speaking to the Federation of German Industries Conference in Germany last week, John Lechleiter, chairman,…

Eli LillyEuropePharmaceuticalPoliticsPricingRegulation

Amylin and Lilly to re-file Bydureon with US FDA sooner than expected with new tQT data


Amylin Pharmaceuticals (Nasdaq: AMLN), Eli Lilly (NYSE: LLY) and Alkermes (Nasdaq: ALKS) have announced…

AlkermesAmylinBydureonDiabetesEli LillyPharmaceuticalRegulationResearch

Novartis’ Afinitor meets primary endpoint in Ph III SEGAs brain tumor study


Just days after demonstrating positive results in breast cancer, Swiss drug major Novartis (NOVN: VX)…


New Greek drug Price Bulletin now published, despite industry arguments


Following the intensive efforts of the Secretariat General of the Greek Ministry of Health, which is…


China’s monoclonal antibody industry growing but still lagging USA and Europe


China has been engaging in monoclonal antibody R&D for some time, but still lags far behind European…

Asia-PacificBiotechnologyMarkets & MarketingMerck KGaAOncologyPharmaceuticalRoche

HUYA Bioscience and Biolake collaborate to boost China’s pharma innovation platform


San Diego, USA-headquartered HUYA Bioscience International, a leader in globalizing China’s pharmaceutical…

Asia-PacificBiolakeBiotechnologyHUYA BiscienceLicensingPharmaceuticalResearch

Qiagen to buy 61% stake in Ipsogen, aiming to take full control of the molecular diagnostics firm


Netherlands company Qiagen (Nasdaq: QGEN) has entered into binding agreements with a group of major shareholders…

IpsogenMergers & AcquisitionsPharmaceuticalQiagen

New date set for hearing of the Kenya Anti-Counterfeit court case


Hearings of the constitutional case challenging the implementation of the Kenya Anti-Counterfeit Act,…

GenericsLegalRest of the World

CV events halt Sanofi Multaq trial; Merck KGaA drops Idera cancer drug on safety concerns


In two clinical disappointments announced yesterday, French drug major Sanofi (Euronext: SAN) and Germany’s…

Cardio-vascularIdera PharmaceuticalsMerck KGaAMultaqOncologyPharmaceuticalResearchSanofi

Pfizer confirms it is viewing options, including sale, of its Animal Health and Nutrition businesses


Global drugs behemoth Pfizer (NYSE: PFE), which is facing patent loss on the biggest ever-selling drug,…

FinancialMergers & AcquisitionsPfizerPharmaceutical

OHE report recommends “prize” system to boost R&D in fight against superbugs


A new report today by the Office of Health Economics (OHE), which is linked with the Association of the…

Antibiotics and Infectious diseasesFinancialPharmaceuticalResearch

7894 to 7918 of 8454 results

Back to top